Silva Ljevar

6PUBLICATIONS
57CO-AUTHORS
Haematological tumoursChemotherapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 05, 2025
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis.

Anna Dodero, Giusy Ceparano, Beatrice Casadei

|Jul 02, 2024
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas.

Federico Stella, Annalisa Chiappella, Beatrice Casadei

|Feb 15, 2024
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma.

Cristiana Carniti, Nicole M Caldarelli, Luca Agnelli

|Dec 08, 2022
Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study.

Marco Fiore, Silva Ljevar, Sandro Pasquali

|Jul 27, 2022
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer.

Valentina Doldi, Mara Lecchi, Silva Ljevar

|May 18, 2022
Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma.

Chiara Monfrini, Federico Stella, Vanessa Aragona

Pageof 1

Frequent Collaborators

4 joint publications

Paolo Corradini

3 joint publications

Federico Stella

3 joint publications

Annalisa Chiappella

2 joint publications

Ilaria Cutini